MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. CHE
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Chemed (CHE) Stock Fundamentals, Analysis & Risk Signals

Health score, competitive moat, risk signals, and key metrics at a glance.

NYSE•Healthcare•Medical Care Facilities
B
GoodMetricSide Score: 63/100
ProfitabilityProfit25/30
GrowthGrowth9/25
Balance SheetBalance13/25
Cash QualityCash16/20
Price & Volume
Market Cap $6.70B

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Moat Signals

Competitive analysis based on 64 quarters of fundamental data

Pricing Power

Moderate Moat

Operating margins are positive at ~14.3% on average, but show some variability — pricing power may be sensitive to market conditions.

Competitive Advantage

Strong Moat

Consistently high ROE averaging 26.3% suggests a durable competitive advantage and efficient capital allocation.

Cash Generation

Strong Moat

Free cash flow is consistently positive and growing — a hallmark of a capital-light business that can self-fund growth.

Demand Durability

Strong Moat

TTM revenue has grown consistently (6 of 7 quarters up), with ~8.8% growth over the period. Strong demand durability.

Risk Signals

Data-driven red flags and warnings across 64 quarters

Low Risk

Margin Pressure

Watch

Operating margins declined 17.4% — watch for continued compression, which may signal competitive or cost pressure.

Earnings Quality

Healthy

FCF covers net income by 1.2x on average — earnings are well-supported by cash generation.

Leverage Risk

Healthy

Limited debt-to-equity data available.

Revenue Decline

Healthy

Revenue is stable or growing over recent quarters — demand appears durable.

Cash Burn

Healthy

Free cash flow is consistently positive — the business self-funds without external capital reliance.

Share Dilution

Healthy

Shares decreased 9.4% — net buybacks are reducing shares outstanding and boosting per-share value.

Metrics at a Glance

as of March 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$2.54B
2.1%
Q. Revenue
$657.51M
TTM EBITDA
$393.76M
12.9%
TTM Op. Income
$328.07M
15.6%
Q. Op. Income
$84.58M
TTM Net Income
$259.78M
15.9%
Q. Net Income
$66.30M
EPS
$4.85
Shares Out.
$13.68M
6.5%
$2.54B in TTM revenue grew 2.1% YoY, reaching $657.51M last quarter. TTM EBITDA of $393.76M and TTM operating income of $328.07M shows growth is flowing through. Net income of $259.78M TTM confirms the company is converting revenue into profit. Revenue is growing modestly — monitor for acceleration or deceleration.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin
32.8%
1.9%
EBITDA Margin
15.4%
Op. Margin
12.9%
12.2%
Net Margin
10.1%
9.1%
Op. margin of 12.9% is down 1.8% YoY — costs are rising relative to revenue. Net margin at 10.1% and gross margin of 32.8% — earnings take a bigger bite when COGS stays lean..

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
25.8x
P/S Ratio
2.6x
P/B Ratio
7.9x
At 25.8x P/E, the stock trades in line with market averages — fairly valued. P/S of 2.6x and P/B of 7.9x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$1.54B
Cash
$16.86M
Long-Term Debt
$91.20M
Book Value
$847.99M
D/E Ratio
0.1
Debt/EBITDA
0.9
With $1.54B in assets and $91.20M in long-term debt, the D/E of 0.1and book value of $847.99M — shows a conservative capital structure — the company has a strong financial cushion to weather downturns.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$88.22M
Free Cash Flow
$71.10M
265.3%
FCF Margin
2.8%
FCF / Net Income
1.1
FCF of $71.10M on $88.22M in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention.

Related Stocks in Healthcare

View Sector
NVDA$4.57T
Nvidia
Semiconductors
GOOG$3.96T
Alphabet Inc. (Class C)
Internet Content & Information
AAPL$3.67T
Apple Inc.
Consumer Electronics
GOOGL$3.66T
Alphabet Inc. (Class A)
Internet Content & Information
MSFT$3.46T
Microsoft
Software - Infrastructure
AMZN$2.56T
Amazon
Internet Retail
META$1.66T
Meta Platforms
Internet Content & Information
AVGO$1.63T
Broadcom
Semiconductors